These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 9351062)
1. Molecular mechanisms of immunosuppressive chemical agents recently introduced in clinical transplantation protocols. Lang P; Baron C Nephrol Dial Transplant; 1997 Oct; 12(10):2050-4. PubMed ID: 9351062 [No Abstract] [Full Text] [Related]
2. Clinical and experimental immunosuppression. Castillo Lugo JA Bol Asoc Med P R; 1995; 87(5-6):106-8. PubMed ID: 8573248 [No Abstract] [Full Text] [Related]
8. Immunosuppressive agents: recent developments in molecular action and clinical application. Gerber DA; Bonham CA; Thomson AW Transplant Proc; 1998 Jun; 30(4):1573-9. PubMed ID: 9636637 [No Abstract] [Full Text] [Related]
9. [Advances in the fundamentals and therapeutic use of immunosuppressive agents]. Ochiai T Arerugi; 1992 Mar; 41(3):381-4. PubMed ID: 1374229 [No Abstract] [Full Text] [Related]
10. Immunosuppressive approaches to the prevention of graft vascular disease. Gregory CR Transplant Proc; 1998 May; 30(3):878-80. PubMed ID: 9595134 [No Abstract] [Full Text] [Related]
11. New horizons in immunosuppression. Simmons RL; Wang SC Transplant Proc; 1991 Aug; 23(4):2152-6. PubMed ID: 1714645 [No Abstract] [Full Text] [Related]
13. New antirejection drugs anticipated. Randall T JAMA; 1990 Sep; 264(10):1225. PubMed ID: 1696999 [No Abstract] [Full Text] [Related]
14. Clinically significant drug interactions with new immunosuppressive agents. Mignat C Drug Saf; 1997 Apr; 16(4):267-78. PubMed ID: 9113494 [TBL] [Abstract][Full Text] [Related]
15. Review of immunosuppression for lung transplantation. Novel drugs, new uses for conventional immunosuppressants, and alternative strategies. Hausen B; Morris RE Clin Chest Med; 1997 Jun; 18(2):353-66. PubMed ID: 9187827 [TBL] [Abstract][Full Text] [Related]
16. Effective and safe use of FK 506: combination treatment with rapamycin or RS-61443 in experimental organ transplantation. Ochiai T; Gunji Y; Nagata M; Asano T; Isono K Transplant Proc; 1991 Dec; 23(6):2718-9. PubMed ID: 1721255 [No Abstract] [Full Text] [Related]
17. Balancing efficacy and toxicity in kidney-transplant immunosuppression. Leichtman AB N Engl J Med; 2007 Dec; 357(25):2625-7. PubMed ID: 18094383 [No Abstract] [Full Text] [Related]
18. Efficacy of rapamycin, RS-61443, and cyclophosphamide in the prolongation of survival of discordant pig-to-rabbit cardiac xenografts. Yatscoff RW; Wang S; Keenan R; Chackowsky P; Koshal A Transplant Proc; 1994 Jun; 26(3):1271-3. PubMed ID: 8029905 [No Abstract] [Full Text] [Related]
19. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months. Gonwa T; Mendez R; Yang HC; Weinstein S; Jensik S; Steinberg S; Transplantation; 2003 Apr; 75(8):1213-20. PubMed ID: 12717205 [TBL] [Abstract][Full Text] [Related]